baber/WOPTO huggingface dataset:
Patent NZ-514382-A (NZ)
Title: C10 ester substituted taxanes as antitumor agents
Inventor: HOLTON ROBERT A
IPC: C07D409/12
Filed: 2001-02-02
Abstract: A pharmaceutical composition comprising a taxane of formula (I), wherein X3 is substituted or substituted heterocyclo; X5 is -COX10, -COOX10, or -CONHX10; and the remaining substituents are defined herein.
Patent NZ-516546-A (NZ)
Title: Method of producing glyphosate or a salt thereof
Inventor: MULLER ULRICH
IPC: C07F9/38
Filed: 2000-07-21
Abstract: A process for preparing N-phosphono methylglycine or a salt thereof by contacting phosphono methyl iminodiacetic acid or a salt thereof with at least one oxygen contacting oxidant in the presence of a heterogeneous catalysts comprising at least one silicate. The oxidant can be a hyperoxide, gases containing molecular oxygen, oxygen donating compound or nitrogen oxides.  The silicate can be zeolites, sheet silicates, clay mineral, or clathrasil.
Patent NZ-517385-A (NZ)
Title: Wallboard joint material containing barium sulphate
Inventor: GREIG MICHAEL STUART MCRAE
IPC: G21F3/00
Filed: 2002-02-21
Abstract: A drywall wall or ceiling lining system having a required level of X-ray transmission resistance, includes: a plurality of X-ray transmission resistant gypsum wallboards (2, 3), wherein at least one joint or gap between an adjacent two or more of the X-ray transmission resistant wallboards (2, 3) is provided with a drywall jointing compound (8) including at least 30% by weight of barium sulphate.
Patent NZ-518021-A (NZ)
Title: Phytochemicals for treatment of mastalgia and endometriosis
Inventor: ZELIGS MICHAEL A
IPC: A61K36/752
Filed: 2000-09-22
Abstract: A pharmaceutical composition comprising an amount of  a dietary   indole   effective  to  treat  or   prevent   pain associated with mastalgia or endometriosis.
Patent NZ-523656-A (NZ)
Title: Pyrazole derivatives and their use as protein kinase inhibitors
Inventor: COOPER CHRISTOPHER BLAIR
IPC: A61P25/00
Filed: 2001-08-24
Abstract: Pyrazole derivative compounds of formula (1), and their pharmaceutically acceptable salts are disclosed, wherein R1, R2, R3, and R4 are as defined in the specification. Compounds of formula (1) are indicated to have activity inhibiting cdk2, and GSK-3. Pharmaceutical compositions comprising compounds of formula (1) and methods for treating and preventing diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission are also described. Compounds of formula (1) may be suitable for treating male fertility and sperm motility; diabetes mellitus; impaired glucose tolerance; metabolic syndrome or syndrome X; polycystic ovary syndrome; adipogenesis and obesity; myogenesis and frailty, for example age-related decline in physical performance; acute sarcopenia, for example muscle atrophy and/or cachexia associated with burns, bed rest, limb immobilization, or major thoracic, abdominal, and/or orthopedic surgery; sepsis; hair loss, hair thinning, and balding; and immunodeficiency.
Patent NZ-523770-A (NZ)
Title: Hexahydro-7-1H-azepin-2-YL-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase
Inventor: HANSEN DONALD W
IPC: A61P1/06
Filed: 2001-08-01
Abstract: A compound of formula as shown is disclosed used to treat or prevent nitric oxide synthase-mediated disorders. Other compounds with similar pharmacophores are also disclosed.
Patent NZ-527447-A (NZ)
Title: The method for prophylaxis or therapy of AIDS with a formulation comprising mycobacterium w or immunomodulator obtained therefrom
Inventor: KHAMAR BAKULESH MAFATLAL
IPC: A61K39/00
Filed: 2002-01-17
Abstract: Human Immunodeficiency virus causes depletion of CD4 cells. The depletion of CD4 cells results in decrease in immunity of an infected individual. Due to this decrease immunity various opportunistic infections occur. These infections are cause for morbidity and mortality in HIV infected individuals. The treatment of HIV these includes antiretroviral drugs. These drugs have their own side effects and immune reconstitution achieved is delayed and slow. Various attempts have been made to improve CD4 count, use of IL-2 is one of them. It is associated with systemic side effects during the period of its administration. Described is an immunomodulator based on Mycobacterium w. Its use is associated with symptomatic improvement as well as improvement in immunity as evidenced by an increased CD4 count in HIV infected individuals.
Patent NZ-532297-A (NZ)
Title: Virulence genes, proteins, and their use in treating conditions associated with infection by Neisseria or gram-negative bacteria
Inventor: TANG CHRISTOPH
IPC: A61P31/04
Filed: 2001-05-08
Abstract: A series of genes from Neisseria meningitidis are shown to encode gene products that are implicated in virulence. The identification of these genes therefore allows attenuated microorganisms to be produced. Furthermore, the genes or their encoded products can be used in the manufacture of vaccines for therapeutic application, including veterinary treatment. In particular the nucleotide sequence designated SEQID NO. 157 that encodes amino acid sequence designated SEQ ID NO. 158 are described.
Patent NZ-533371-A (NZ)
Title: Vectors for plant transformation contaning mostly or exclusively genetic material from plants useful with Agrobacterium transformation system
Inventor: CONNER ANTHONY JOHN
Filed: 2004-06-08
Abstract: Disclosed is plant transformation vectors, methods for transforming plants and transformed plants. The vectors are designed to avoid incorporation of non-plant DNA into the plant genome. Also disclosed is the use of plant sequences selected from sequences functioning as T-DNA border sequences, selectable markers, recombinase recognition sequences and origins of replication. Further disclosed is the use of additional plant sequences contiguous to border sequences.
Patent NZ-533496-A (NZ)
Title: Electric fence wire reeling apparatus with tension actuated motor drive
Inventor: KENNEDY PETER
Filed: 2004-06-14
Abstract: Strands of electric fence wire may be unwound from or wound onto respective reels 2A, 2B, 2C by motor 6 and gearing. Control is via the reels and by association with a perimeter wire connectable to the apparatus, tension switch and multifunction switch.
Patent NZ-534165-A (NZ)
Title: A plectrum with connecting portion connecting two picking portions for grasping
Inventor: LEONG WENG ONN
IPC: G10D3/16
Filed: 2001-12-21
Abstract: A plectrum (1) is disclosed having two portions (10, 12) being offset transversely but connected integrally by a stepped member (14). One portion (12) may have a tear-drop shaped playing edge (112), while the other portion may have a pointed edge (114) at one corner and another short pointed edge (118) at the second corner. A scallop playing edge (116) is typically joined to the short pointed edge (118). The stepped edge (14) is preferably in the shape of an arc. Other embodiments include a plectrum (1a, 1b, 1c, 1d) having a planar body (20) with a tear-drop shaped playing edge (112a, 112b, 112c, 112d), a pointed playing edge (114a, 114b, 114c, 114d) and a short pointed edge (118a, 118b, 118c, 118d). A scallop shaped edge (116a, 116b, 116c, 116d) may be joined to the short playing edge (118). On the faces of the plectrum is preferably a ridge (201), a groove (202) or a combination of a ridge (201) and a groove (202) on the same or opposed face. The ridge or groove is optionally disposed across the centre of the plectrum and is in the form of an arc. The curved stepped edge (14) or the edges of the curved ridge (201) or groove (202) seek to provide a positive grip on the plectrum. The curved edges are also formed to fit comfortably with the curve of the user's thumb or finger.
Patent NZ-535409-A (NZ)
Title: Tightly covered container
Inventor: OZASA AKIO
IPC: B32B7/027
Filed: 2003-02-20
Abstract: A bowl-type container (10a) wherein a coating film (12) comprising a biodegradable plastic as the main component and having at least hydrophobic nature is bonded to the surface of a container body (11a) comprising starch as the main component. The container body is produced by moulding a water-containing material in the form of a slurry or a dough by steam-expansion and can exhibit a highly favourable biodegradability.
Patent NZ-535729-A (NZ)
Title: CD40 binding molecules or 4-1BB binding molecules used in a monotherapy for the treatment of a tumour or infectious agent by induction of systemic T-cell immunity against the tumour antigen
Inventor: DIEHL LINDA
IPC: C07K16/28
Filed: 2003-04-04
Abstract: Disclosed is a method and composition for treating tumours or infectious diseases, wherein the composition comprises an agonistic anti-CD40 antibody or a fragment thereof in a monotherapy which stimulates the CD40 receptor. The agonistic antibody molecules include fragments like Fab, (Fab')2 and Fv. The methods and compositions may further comprise polypeptides or nucleic acid sequences having or encoding a class 1 MHC or class II MHC-restricted T cell epitope.
Patent NZ-536978-A (NZ)
Title: A data acquisition unit, system and method for geophysical data
Inventor: DUNCAN ANDREW CHARLES
IPC: G01V3/38
Filed: 2003-06-20
Abstract: A data acquisition system for gathering geophysical data, a corresponding method, and a data acquisition unit for use with the system and method are disclosed. The system (10) comprises a plurality of data acquisition units (14) for gathering geophysical data, each data acquisition unit (14) being connectable to at least one sensor (15), and arranged during use to gather geophysical data from the at least one sensor (15). Each data acquisition unit (14) comprises time referencing means (48) arranged to generate time reference data usable to control the time at which samples of geophysical data are taken. The system (10) further comprises means for calculating spatial derivatives between samples associated with adjacent sensors (15) connected during use to the data acquisition units (14).
Patent NZ-542823-A (NZ)
Title: 2-Alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
Inventor: NEUSTADT BERNARD R
IPC: A61P25/16
Filed: 2004-04-21
Abstract: 2-Alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine compounds having the structural formula (I) or a pharmaceutically acceptable salt thereof are disclosed, wherein R is -C=CR6; R1, R2, R3, R4 and R5 are H, alkyl or alkoxyalkyl; R6 is H, alkyl, hydroxyalkyl or -CH2F; R7, R8 and R9 are H, alkyl, alkoxy, alkylthio, alkoxyalkyl, halo or -CF3; and Z is optionally substituted aryl, heteroaryl or heteroaryl-alkyl, (the variables are further defined in the specification). Also disclosed is the use of compounds of formula (I) in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.
Patent NZ-543121-A (NZ)
Title: Soil cultivating and sowing apparatus with slotted tines aligned longitudinally with seeding tines so as not to disturb soil between seed rows
Inventor: CLAYDON JEFFREY THOMAS
IPC: A01B49/06
Filed: 2004-03-25
Abstract: Soil cultivating and seed sowing apparatus is disclosed. The drawing shows the apparatus from the rear with slotter tines 16 located in advance of seeding tines 14 with each in rows such that respective slotter tines 16 and seeding tines 14 are aligned in a direction of travel. The tines are carried by a frame which is towed by or attached to the rear of a tractor and each row of tines is spaced apart across the width of the frame. Seeds are fed from a hopper to the rear and underside of the seeding tines. Wheels 22, behind each seeding tine, level and firm the soil. With such an arrangement it is stated that strips of soil between the tines will not be disturbed.
Patent NZ-543791-A (NZ)
Title: Packaging for bitumen
Inventor: MARCHAL JEAN-LUC ALBERT VITAL
Filed: 2003-04-30
Abstract: A consumable bitumen packaging compound including at least one packaging material/s, such as polymers, plastics and extenders and the like, used in combination with the bituminous material and a metal, either pure in powder form or in the form of salt or oxide, that is physically and/or chemically combined with the polymer material, so that the density of the packaging material is adjusted to prevent the material from floating to the surface of the molten material after melting. The components of the packaging are preferably selected such that they are compatible with the bitumen. After transport and storage, the packaging material can therefore be directly incorporated into the bitumen product for final use, such that the formation of a polymer skin accumulating at the surface of the molten material is largely avoided.
Patent NZ-552152-A (NZ)
Title: Power control for a wireless communication system utilizing orthogonal multiplexing
Inventor: SUTIVONG ARAK
IPC: H04B7/005
Filed: 2005-06-07
Abstract: A method of reporting interference in a wireless communication system is disclosed. The method includes: estimating interference observed at a base station; forming an interference report for the estimated interference; broadcasting the interference report via a wireless channel; comparing the estimated interference against a first interference threshold; and setting a first bit based on whether the estimated interference is above or below the first interference threshold. The interference report comprises the first bit.
Patent NZ-552325-A (NZ)
Title: The use of alpha 2 andrenoceptor agonists such as brimonidine for treating inflammatory skin disorders
Inventor: DEJOVIN JACK
IPC: A61K31/137
Filed: 2005-05-25
Abstract: Disclosed is the use of a compound selected from brimonidine, naphazoline, oxymetazoline, xylometazoline, norepinephrine and methoxamine, pharmaceutically acceptable salts thereof or combinations thereof, for topical administration to treat or prevent an inflammatory skin disorder. More generally disclosed is the use of alpha 2 andrenoceptor agonists to treat inflammatory skin conditions.
Patent NZ-556544-A (NZ)
Title: Human papillomavirus polypeptides and immunogenic compositions
Inventor: SMITH LARRY
IPC: A61K39/12
Filed: 2003-10-02
Abstract: Provided is a polypeptide comprising human papillomavirus E6 and E7 polypeptides, wherein the E7 polypeptide has mutations at any one or more of the amino acids corresponding to amino acids 24,26 or 91 of a specified polypeptide and the E6 polypeptide has no mutations or has mutations at any one or more of the amino acids corresponding to amino acids 63 or 106 of a specified E7 polypeptide and the mutant polypeptide retains at least approximately 30% of the immunogenicity of an isolated peptide comprising human wild-type papillomavirus E6 and E7. Further provided are corresponding expression vectors, host cells comprising the vector, immunogenic compositions and use of the compositions for the manufacture of medicaments to produce an immune response and to treat cervical cancer.
Patent NZ-560892-A (NZ)
Title: Roof sheeting clip to lockingly engage a roofing sheeting panel
Inventor: THOMSON JEFFREY
Filed: 2007-08-24
Abstract: A retaining member (10) for locking a ribbed panel (30) to a support structure comprises a body (15) and a pair of wings (11), (12). The body is adapted to be affixed to the support structure and said wings (11), (12) are resiliently deformable and in a disengaged condition extend substantially perpendicularly to the body and in an engaged condition are pressed into a swept configuration wherein the wings lockingly engage lands (34), (35) disposed on sidewalls (32), (33), (37), (38) of a channel (31) of the panel (30).
Patent NZ-567208-A (NZ)
Title: Pyrimidine amide compounds as PGDS inhibitors
Inventor: ALDOUS SUZANNE C
IPC: A61K31/506
Filed: 2006-10-04
Abstract: Disclosed are pyrimidine amide compounds of formula (I) or hydrates, solvates, N-oxides or pharmaceutically salts thereof, wherein R1 is an aryl, heteroaryl or (C5-C6)-cycloalkyl and the rest of the substituents are disclosed within the specification. Also disclosed is the use of the said compound of formula (I) for the preparation of a medicament for the treatment of an allergic or inflammatory disorder.
Patent NZ-568471-A (NZ)
Title: New process for the preparation of esomeprazole non-salt form
Inventor: BOHLIN MARTIN
IPC: A61K31/4439
Filed: 2006-12-04
Abstract: Disclosed is a process for preparing esomeprazole non-salt form comprising essentially the following steps: i) dissolving a base addition salt of esomeprazole in water containing at least one amine B1; ii) adding at least one acid Ha1; iii) allowing esomeprazole non-salt form to crystallize and isolate the formed crystals.
Patent NZ-572958-A (NZ)
Title: Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
Inventor: ZHENG XIAOHUI
IPC: C07D407/12
Filed: 2007-05-14
Abstract: Disclosed is a substituted phenyl compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) include 2-hydroxyl-3-(benzo[1,3]-dioxol-5-yl)- N-[2-hydroxyl-3-(1-naphthoxy)propyl]-propionamide; beta-(benzo[1,3]-dioxol-5-yl)- á-hydroxyl-N-(3-phenyl-1-ethoxycarbonyl-propyl)propionamide and menthyl beta-(benzo[1,3]dioxol-5-yl)- alpha-(nicotinoyloxy)propionate ester. Also disclosed is the process for preparing a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for the prevention or treatment of cardiovascular or cerebrovascular disease.
Patent NZ-578339-A (NZ)
Title: Spinach line SMB66-1086M
Inventor: BAERENDS BERNARDUS
IPC: A01H5/12
Filed: 2009-07-10
Abstract: Disclosed is a seed of Spinach line SMB66-1086M a sample of seed of said line having been deposited under ATCC Accession Number PTA-9189. Also disclosed are corresponding plants and tissue cultures, and the use of the plants in plant breeding.
Patent NZ-583035-A (NZ)
Title: Method and device for spraying a pulverulent material into a carrier gas
Inventor: DI LORETO OSVALDO
IPC: B05B7/14
Filed: 2008-07-03
Abstract: Disclosed is a method for spraying a pulverulent material into a carrier gas. The method comprises a flow of the carrier gas being pressurized, an acceleration of the pressurized carrier gas to a sonic velocity, and an expansion of the pressurized carrier gas with formation of a negative pressure zone having a pressure lower than the carrier gas flow pressure. The method further comprises an entrainment of an amount of the pulverulent material by the expanded carrier gas, and a spray of the pulverulent material entrained by the carrier gas. The lower pressure is adjusted by the bypassing or not, before the expansion, of an adjustable amount of the carrier gas having been accelerated, to reintroduce the adjustable amount into the negative pressure zone without changing the total flow rate of the carrier gas. Further disclosed is a device capable of performing this method.
Patent NZ-583817-A (NZ)
Title: Post-harvest treatment of cut flowers, vegetables and fruits using tebuconazole
Inventor: HAUSER-HAHN ISOLDE
IPC: A01N3/02
Filed: 2008-09-02
Abstract: Disclosed is the use of tebuconazole and salts thereof to protect harvested fruit, cut-flowers or vegetables against phytopathogenic fungi such as Fusarium spp.; Verticillium spp.; Nigrospora spp.; Alternaria spp.; Phytophthora spp.; Septoria spp.; Mucor spp.; Venturia spp.; Glomerella spp.; Sclerotinia spp.; Ceratocystis spp.; Gloeosporium spp.; Phlyctaena spp.; Cylindrocarpon spp.; Stemphyllium spp.; Phacydiopycnis spp.; Thielaviopsis spp.; Aspergillus spp.; Nectria spp.; and Pezicula spp.
Patent NZ-586188-A (NZ)
Title: Remote sensing and probabilistic sampling based method for determining the carbon dioxide volume of a forest
Inventor: KELLE OLAVI
IPC: A01G23/00
Filed: 2008-12-19
Abstract: A remote sensing and probabilistic sampling based method for determining the carbon dioxide volume of a forest is disclosed. The carbon dioxide volume is a volume of carbon sequestered by the forest. The method comprises processing remote sensing data indicative of tree attribute information for the forest. The remote sensing data (52) comprises at least one of LiDAR data and digital images. The method further comprises defining a sampling frame within the remote sensing data; determining a field plot corresponding to the sampling frame and collecting field plot data (54) therefrom. The field plot data comprises actual tree attribute information. The method further comprises generating a correlated model (56) by combining the field plot data with the remote sensing data corresponding to the sample frame; applying the correlated model to all the remote sensing data to produce a probabilistic forest inventory; and determining a probabilistic carbon dioxide volume of the forest utilizing the probabilistic forest inventory. Also disclosed is a remote sensing and probabilistic sampling based method for determining the carbon dioxide volume of a forest. The carbon dioxide volume is a volume of carbon sequestered by the forest and the method comprises processing imagery data, the imagery data indicative of tree attribute information for the forest; classifying tree polygons within the imagery data to derive the tree attribute information; correlating field data, the field data comprising at least one of actual tree attribute formation and plot centre location; generating a correlated model utilizing the tree attribute information derived from the imagery data and the actual tree attribute information; generating a probabilistic forest inventory by applying the correlated model to all the imagery data; and determining a probabilistic carbon dioxide volume of the forest utilizing the probabilistic forest inventory.
Patent NZ-591234-A (NZ)
Title: [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
Inventor: CHOY NAKYEN
IPC: A61P29/00
Filed: 2009-08-20
Abstract: Disclosed is 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide (as pictured) a prodrug, pharmaceutically acceptable salt or solvate thereof. Also disclosed is a crystalline form, a c a compound of formula (I) the use of a compound in the manufacture of a medicament for treating conditions by inhibiting tryptase and a method for preparing a compound of formula (I). Diseases treated by inhibition of trypase are for example: asthma, bowel diseases and fibrosis.
Patent NZ-593757-A (NZ)
Title: Rifaximin complexes
Inventor: GHAGARE MARUTI GANPATI
IPC: A61K47/48
Filed: 2009-12-09
Abstract: Disclosed herein are complexes comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP), preferably having a K-value ranging from K-15 to K-90, specifically K-30; or a cyclodextrin, preferably selected from ?-cyclodextrin, ?-cyclodextrin or ?-cyclodextrin; with the proviso that the complexing agent is not hydroxybutenyl cyclodextrin or a derivative thereof. Said complexes are useful in the treatment of bowel related disorders such as irritable bowel syndrome, diarrhoea, traveller's diarrhoea, microbe associated diarrhoea, Crohn's disease, chronic pancreatitis, pancreatic insufficiency and/or colitis.
Patent NZ-596301-A (NZ)
Title: Novel 7-deazapurine nucleosides for therapeutic uses
Inventor: HOCEK MICHAL
IPC: C07H19/14
Filed: 2010-04-19
Abstract: Disclosed are 7-(-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I, wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds. These compounds are suitable for treating a cellular proliferation disease or a neoplastic disease or a tumor or cancer.